EBG MedAustron GmbH
The project concerns the design, construction and operation of a hadrontherapy centre, the purpose of which is to undertake systematic clinical and non-clinical research into the use of proton and ion therapy in the treatment of cancer.
The project could contribute to much needed clinical research on the efficacy of proton and ion therapy as treatment options for cancer.
The promoter has indicated that, according to Austrian law, an Environmental Impact Assessment is required for the construction of new particle accelerators providing energies of more than 50MeV. Since the MedAustron accelerator exceeds this threshold, an environmental impact assessment has been requested by the local authority and was approved on 20th January 2011. The environmental impact of the project, as well as the EIA process will be assessed during appraisal.
The promoter will follow public procurement rules. Procurement procedures being followed will be verified during appraisal.
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.